Corporate
Spero Founder Exits Board Two Weeks After SEC Settlement
Jan 30
You're signed outSign in or to get full access.
ST
Spero Therapeutics (SPRO)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Spero Therapeutics.